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Summary 
Spontaneous inflammatory bowel disease  (IBD) resembling human ulcerative colitis develops 
in mice mutant for the T  cell receptor ct gene (TCR.-ix-/-). TCP,.-et  -/- mice lack TCR.-el/ 
13 +  cells but contain TCR-',//~  +  cells  and a small population of a unique  CD4 +,  TCR.-0t-/ 
[~+0ow) cells.  Since all the immunoglobulin (Ig) classes are present in these mice, help to B cells 
must be provided by cells other than TCR-o#[~ + cells.  In the present study, we found serum 
levels of IgG1 and IgG2 to be markedly increased in TCR-oL  -/- mice with IBD as compared 
to TCR.-0t -/- mice without IBD or TCR-ct +/- controls. An increase in IgGl-, IgG2a- and 
IgA- but not IgM-secreting mesenteric lymph node (MLN) B cells was detected in TCR-~x  -/- 
mutant mice. There was also a marked increase in MLN B cells secreting autoantibody (lgG) to 
tropomyosin, a cytoskeletal protein. Examination of the hyperplastic MLN showed a marked 
increase in the number of B, TCok-8  +, and CD4 + TCR-a-/[3 + cells, similar to the cell popu- 
lation observed at the site of colonic inflammation. Analysis of spontaneous cytokine produc- 
tion by MLN cells using an enzyme-linked immunospot assay, immunohistochemistry, and re- 
verse transcription-polymerase chain reaction showed a decrease of interleukin 2  (IL-2) but a 
marked increase oflL-4 and interferon ~/(IFN-~/) production in TClk-0t  -/- mice with IBD as 
compared to TCR-ot  -/- mice without IBD and TCR.ix +/- control mice. Both TCR-oe-/~ + 
and TCR.-g  + cells were found to be capable of producing IL-4; IFN-~/was produced mostly 
by non-T cells, many of which were shown to be CD3- NK 1.1 + cells. We propose that the 
cytokine  imbalance  present  in  these  mice  results  in  expansion  of B  cells,  production  and 
switching of autoantibodies to IgG2 subclass,  and development of IBD. It is possible that the 
unusual  CD4 +  TCI~-~x-/[~  +  population  and  expanded  TCR.-~//~ +  population  present  in 
TCR-oL  -/- mice plays a central role in this abnormal immune response. 
H 
elp  for  antibody  responses  is  typically provided  by 
.CD4 +  TClk-ot/~ T  cells.  CD4 §  T  cells  can be di- 
vided into two functional subsets based on their production 
of cytokines. Thl  cells secrete IL-2, IFN-~/, and TNF and 
are  the  primary effector T  cells  involved in  delayed-type 
hypersensitivity responses  and  cellular immunity to  intra- 
cellular pathogens. Thl-derived cytokines (IFN-'~) also sup- 
port switching to the IgG2a isotype. By contrast, Th2 cells 
are primarily involved in B  cell activation and maturation, 
mediated by their secretion of IL-4, IL-5, IL-6, IL-10, and 
IL-13. Th2-derived cytokines direct switching to IgG1 and 
IgE isotypes (1-3). In TCR.-cl  -/- mice, created by target- 
ing TCP.-0L genes in embryonic stem cells,  the population 
of T  cells  is composed of TCP.-~//8 +  cells  and unique  T 
cells bearing a TClk-13 chain on the cell surface in the ab- 
sence  of a TCR-~x chain  (4,  5).  The TCP.-~//8 +  T  cells 
normally develop and increase with age (4)  or pathogenic 
infection (6),  These mice can produce antibodies of all Ig 
subclasses  (7,  8), suggesting that other cell types can drive 
antibody responses and isotype switching in the absence of 
TCI~-o~/~ T  cells (9).  However, mucosal immunoregula- 
tory mechanisms are also apparently affected by the absence 
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velop an ulcerative colitis (UC)l-like inflammatory bowel 
disease (IBD) (7,  10). Compared to other autoimmune dis- 
eases,  the  etiological factors of UC,  an  organ-specific au- 
toimmune  disease,  remain  unknown  because  of a  lack of 
appropriate animal models  (11).  We  have  examined pro- 
duction  of Thl-  and  Th2-derived  cytokines  in  TCR--a 
mutant mice with and without disease. We show here that 
this IBD is associated with the production of autoantibod- 
ies of both Thl-  and Th2-dependent isotypes. The hyper- 
plastic mesenteric  lymph nodes  (MLN)  found  in  diseased 
mice  spontaneously produce increased levels of both  Thl 
(IFN-~/) and Th2 (IL-4) cytokines. IFN-y is produced mostly 
by non-T cells, whereas IL-4 production can be attributed 
to both  TCR-~//8 +  T  cells and  an  unusual population of 
CD4 + TCR-ix-/[3 + T  cells. We suggest that the resulting 
cytokine imbalance in the MLN of diseased TCR-ot -/-  mice, 
perhaps exacerbated by a unique population ofCD4 + TCR- 
ci-/I3  + cells, can promote excessive expansion of B  cells. In 
the  absence  of immunoregulatory  controls  normally pro- 
vided by TCR-c~/[3 T  cells, autoantibody-producing B  cells 
may contribute to the development oflBD in these mice. 
Materials and Methods 
Mice.  Colonies of TCK-ix  -/- mutant mace  (4) were devel- 
oped at Massachusetts  General Hospital from mace provided by 
Drs. P. Mombaerts and S. Tonegawa (Massachusetts  Institute of 
Technology).  These  mice  are  derived genotypically from  two 
(H-2  b) strains,  129/Sv and C57BL/6.  C57BL/6 mace were pur- 
chased from The Jackson Laboratory (Bar Harbor, ME). TCR-a 
heterozygous  mice  (TCR-{x  +/-)  were  generated  by  crossing 
TCR-cl -/- mice with C57BL/6. All of the mice were housed in 
microisolator cages  in  a  specific viral pathogen-free  facility at 
Massachusetts  General Hospital. Food, distilled water, and cages 
were autoclaved at 250~  for 25 rain and changed weekly. 
Antibodies.  For  flow  cytometry,  CD3r  (145-2Cll)-FITC 
(Boehringer  Mannheim  Corp.,  Indianapolis,  IN);  and  B220 
(RA3-6B2),  CD4  (RM4-5),  CD8a  (53-6.7),  CD813 (53-5.8)- 
FITC, TCK-f3 (H57-597), TCR-5 (GL3), and CD5 (53-7.3)-PE 
(PharMingen, San Diego, CA) were purchased. For cell sorting, 
bioin-NK-l.1 (PK136)  was purchased from PharMingen. Anti- 
bodies for Fc-blocking, anti-Fc~/II/llI, and for in vitro stimula- 
tion,  anti-TCR-I3  (H57-597)  and  TCR-8  (UC7)  (all  from 
PharMingen) were used. For capture of enzyme-linked immuno- 
spot (ELISPOT) assay, anti-IL-2 (JES6-1A12), and IL-4 (BVD4- 
1Dll)  (PharMingen), IFN-~/ (RMMG-1; Biosource, Camarillo, 
CA); and anti-immunoglobulin (Ig; Dako Corp., Santa Barbara, 
CA)  were  used.  For detection of ELISPOT,  biotinylated anti- 
IL-2  (JES6-5H4),  IL-4  (BVD6-24G2),  and  IFN-"/  (XMG1.2) 
(Pharmingen); horseradish peroxidase (HRP)-anti-biotin (Vector 
Laboratories, Inc., Burlingame, CA), alkaline phosphatase (AP)- 
anti-Ig and -IgG2a and HRP-anti-IgG1  (Southern Biotechnol- 
ogy Associates, Birmingham, AL); and HRP-anti-lgM, -IgA, and 
IgG (Sera-Lab, Sussex, UK) were used. 
1Abbreviations used in  this paper: ELISPOT, enzyme-linked immunospot; 
HRP, horseradish peroxidase; IBD, inflammatory bowel disease; MLN, 
mesenteric lymph node; SFC, spot-forming cells; UC, ulcerative colitis. 
Histological Analysis.  For histological examination, specimens 
were obtained from four regions: rectum, distal and proximal co- 
lon, and cecum in every mouse tested. Specimens were fixed in 
10% buffered formalin and embedded in paraffin.  Multiple 4-1~m 
sections were stained with hematoxylin and eosin. The severity of 
IBD was determined according to the diagnostic basis previously 
described (7). 
Cell Preparation.  MLN  were  obtained  from  20-26-wk-old 
TCR-ci -/- mice with or without IBD and age-matched TCR- 
ci  +/- mice. After removal of fat, MLN were dispersed gently us- 
ing a 25G needle, and the cell suspensions obtained were passed 
through a 60-p~m nylon membrane. In some experiments, adher- 
ent cells were depleted by incubating the cells in complete me- 
dium (RPMI-1640 containing sodium bicarbonate, nonessential 
amino  acids,  sodium pyruvate, L-glutamine, penicillin, strepto- 
mycin,  and  5%  FCS)  on  tissue  culture  plates,  PRIMARIA  TM 
(Becton  Dickinson  Labware,  Oxnard,  CA),  at  37~  with  5% 
CO2 for 90 rain. After depletion of adherent cells, B  and Fc re- 
ceptor positive cells were depleted by panning. 5 ￿  10  v cells were 
incubated at 4~  for 30 rain in a plate coated with 10 I.tg/ml of 
goat anti-mouse Ig or 10 ~,g/ml ofanti-Fc~/II/llI  in 0.1 M bicar- 
bonate buffer, pH 9.4, overnight at 4~  Nonadherent cells were 
collected and  analyzed for purity by flow cytometry.  The  cell 
population was >93% CD3 + T cells. 
For purification of NK-I.1 + cells, freshly isolated MLN cells 
were incubated with biotin-anti-NK-l.1 mAb for 30 man at 4~ 
followed by a 15-rain incubation at 4~  with streptavidin conju- 
gated with  magnetically activated cell sorting  (MACS  |  super- 
paramagnetic microbeads (Miltenyi, Auburn,  CA). These  com- 
plexes  were  separated  on  the  VarioMACS  system  (Miltenyi). 
Both positive and negative fractions were analyzed by flow cy- 
tometry.  The  positive fraction typically contained ~80%  NK- 
1.1 + cells. 
Colonic mucosal .lymphocytes were extracted according to the 
method for extraction of lamina-propria lymphocytes in intestine 
previously described (12).  Large intestine including rectum and 
colon but not cecum was  dissected free from connective tissue. 
Large intestine was opened longitudinally, cut into small pieces, 
and incubated and rotated in Joklik's medium (Sigma Chemical 
Co.,  St.  Louis, MO)  containing 0.5  btg/ml collagenase type 2 
(GIBCO BRL, Gaithersburg, MD) and 1.5 I~g/ml Dispase for 45 
man at 37~  The tubes were vortexed for 10 s and cell suspen- 
sions were passed through a 70-p~m nylon membrane to remove 
incompletely dissociated epithelial tissue  sheets.  After washing 
with complete medium three times, the cell suspensions were passed 
through a glass-wool column by gravity filtration to remove de- 
bris and epithelial cells. Colonic mucosal lymphocytes were then 
separated using discontinuous 40/72% Percoll gradient centrifu- 
gation for 20 rain at 900 g. After washing with complete medium 
three times, the cells were used for flow cytometric analysis. 
In  Vitro Stimulation.  96-well plates (Coming Glass Inc., Corn- 
ing, NY) were coated with 20 Ixg/ml anti-TCR-~ or anti-TCR-5 
mAb in 100  p,1 of D-PBS at 4~  overnight. After washing with 
PBS  followed by complete medium,  2  >(  10  s  CD3 +  enriched 
cells  (described above)  in  100  ~1  of complete  medium  were 
added to each well. After 3 h at 37~  the nonadherent cells were 
collected and pooled, and the adherent cells were harvested by 
incubation with  1 mM  EDTA  in  Ca  2+,  Mg2+-free HBSS  fol- 
lowed by pipetting. After three washes with complete medium, 
the pooled cells were mixed. 
Single and Two-color Immunohistochemical Analysis.  Tissue  speci- 
mens were embedded in OCT compound, snap frozen in liquid 
nitrogen, and subsequently stored at -80~  Single staining was 
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viously (7). 
Two-color immunohistochemical analysis  was  performed  as 
previously described with the following modification (13). 4-1xm- 
thick specimens were fixed in acetone for 7 min, air-dried, and 
incubated with anti-IL-4 for 1 h at room temperature. For detec- 
tion, biotinylated rabbit anti-rat Ig was used, followed by a 1:100 
dilution of avidin-biotinylated peroxidase complex (Dako). Each 
step was followed by four washes with PBS. The specimens were 
developed in a solution of 3-amino-9 ethylcarbazole (AEC; Ald- 
rich Chemical Co., Milwaukee, WI); the reaction was stopped by 
dipping the specimen in distilled water for 5 rain and washing it 
in PBS  for  10  rain.  The  specimens were  then  incubated with 
anti-TCR-8 at room temperature for 1 h. For detection, biotiny- 
lated goat anti-hamster Ig was used, followed by incubation with 
ABC-alkaline phosphatase reagent (Vector Laboratories, Inc.) for 
30 rain. After development with alkaline phosphatase substrate kit 
III (Vector Laboratories, Inc.)  for  15  rain,  the  specimens were 
postfixed with 2% paraforrnaldehyde and mounted with Glycer- 
gel (Dako). Incubation with 0.3% H202 in PBS was used to block 
endogenous  peroxidase activity, whereas  sequential incubations 
with avidin and biotin (Vector Laboratories, Inc.) were used to 
block endogenous biotin. 
Flow Cytometry.  2-5  ￿  105  MLN  or  mucosal  cells  were 
washed with flow cytometry buffer (PBS  containing 0.2% BSA 
and 0.1% sodium azide), blocked with 50 Ixl of flow cytometry 
buffer containing  10%  normal rat  and  hamster serum  (Jackson 
ImmunoILesearch Laboratories, Inc., West Grove, PA) at 4~  for 
20 rain, and incubated with the FITC and PE mAbs listed earlier 
at  4~  for 40  rain.  After washing with flow cytometry buffer, 
cells were analyzed using Lysis II software on a FACScan  |  flow 
cytometer (Becton Dickinson &  Co., Mountain View, CA). In 
some experiments, anti-Fc~/II/III was used to block Fc-receptor 
(14). 
ELISPOT Assay  for Deteaion of Cytokine-secreting Cells.  To quan- 
titate the  frequency  of IL-2,  IL-4,  or IFN-~/ spot-forming cell 
(SFC), an ELISPOT assay was performed by a modification of a 
previously described method (15).  A 96-well plate with a nitro- 
cellulose base (Millititer HA; Millipore Corp., Bedford, MA) was 
coated overnight at 4~  with 50 Ixl ofanti-IL-2 (10 txg/ml), anti- 
IL-4 (4 Ixg/ml), or anti-IFN-~/(!0 Ixg/ml) mAbs diluted with 0.1 
M bicarbonate buffer, pH 8.4, or D-PBS. After washing, all wells 
were blocked at first with 3% BSA/PBS at 37~  for 1 h, and then 
with complete medium at 37~  for 1 h. In some experiments, de 
novo synthesis of cytokines was blocked by treatment with  50 
I~g/ml cycloheximide (Sigma Chemical Co.). As a positive con- 
trol for IL-2-secreting cells, a ~//8 T  cell hybridoma stimulated 
with the pan B antibody UC7-13D5 was used. Dilutions of 106- 
104 ceils in 100 I~1 of complete medium with or without 5 txg/ml 
Con A (Sigma Chemical Co.) were added to each well and incu- 
bated at 37~  for 14 h. After sequential washes with PBS (three 
times),  distilled  water  (two  times),  0.25%  Tween-PBS  (two 
times), and with 0.05% Tween-PBS (three times), each well was 
blocked again with 3% BSA-PBS at 37~  for 1 h  and incubated 
overnight at  4~  with  100  Ixl of biotinylated mAbs,  2  Ixg/ml 
anti-IL-2, 1.5 p,g/ml IL-4, or 1 ixg/ml IFN-~/in PBS containing 
0.05% Tween and 1% BSA. After washing with 0.05% Tween- 
PBS,  wells were  incubated with  5  Ixg/ml HILP-anti-biotin at 
room temperature for 2  h.  The  spots were developed by AEC 
and counted under a dissecting microscope. 
ELISPOT Assay for Detection of Ig Isotype and of Autoantibody. 
A two- and single-color ELISPOT assay was performed as previ- 
ously described (16).  A  96-well plate with a nitrocellulose base 
was coated overnight at 4~  with 100  bd of tropomyosin (5 Ixg/ 
ml)  (Sigma Chemical Co.)  in 0.1  M  carbonate buffer, pH 9.6, 
(17) or with 100 Ixl of goat anti-mouse Ig (5 Ixg/ml) in PBS. Af- 
ter washing, each well was blocked with 1% BSA-PBS at 37~ 
for 1 h. Dilutions of 2  X  105 to 5 X  102 ceils in 100 ILl of com- 
plete medium were added to each well and incubated at 37~  for 
14 h. After washing with 0.05% Tween-PBS  (five times), HILP 
or AP antibodies to various Ig isotypes were added to each well 
for single-color ELISPOT, or both HILP and AP various Ig iso- 
type antibodies listed above were added simultaneously for a two- 
color ELISPOT assay. After incubation at room temperature for 
2 h, each well was washed and developed with nitroblue tetrazo- 
lium and 5-bromo-4 chloro-3-indolyl phosphate (Promega Bio- 
tec, Madison, WI), followed by development with AEC. 
RT-PCR.  Total ILNA was extracted from MLN cells by the 
acid guanidiniumthiocyanate-phenol-chloroform  method (18) with 
the addition of a treatment with 4 M  LiC1 to remove degraded 
ILNA (19).  IL-2, IL-4, and IFN-',/--specific mRNA were exam- 
ined by a  modified standard ILT-PCIL amplification procedure 
(20). 2 p,g total ILNA was converted to cDNA in 20 t~1 of reac- 
tion buffer (50 mM Tris, pH 8.3, 75 mM KC1, 3 mM MgCI2, 10 
mM dithiothreitol, 500  p,M dNTP,  50  txg/ml oligo(dT)primer, 
and 200 U  murine-leukemia virus reverse transcriptase; GIBCO 
BILL) at 43~  After 45 rain, each tube was heated at 95~  for 5 
min,  cooled briefly on ice, and incubated with 2  U  ILNase H 
(GIBCO BILL) at 37~  for 20 min. The reactions were then di- 
luted five times. Samples of 3 lzl of ILT reactions were amplified 
in 50  Ixl of PCIL mix (10 mM Tris, pH 8.3,  50 mM KC1,  1-2 
mM  MgC12, 0.01%  Triton  X,  0.2  mM  dNTP,  and  1  U  Taq 
DNA polymerase; Perkin Elmer Cetus, Norwalk, CT) with hot 
start (21); 1 ~M of each primer was added at 80~  The primers 
for murine IL-2, IFN-% and 13-actin (Stratagene Inc., La Joila, 
CA) and IL-4 (Clontech Laboratories, Inc., Palo Alto, CA) were 
used in this study. PCR cycling conditions were 36 s at 96~  1 
rain at 60~  and 1 rain at 72~  for 35 cycles after 5 rain at 94~ 
At the end of 35  cycles, samples were held at 72~  for 10 rain 
and then stored at 4~  until analyzed. PCIL products were elec- 
trophoresed in a 3%  Nusieve agarose gel containing 0.5  Ixg/ml 
ethidium bromide and were visualized by UV light illumination. 
ELISA Using Mouse Sera.  Ig levels in sera were measured by 
using 1:100 diluted mouse sera and mouse Ig isotyping ELISA kit 
(PharMingen), according to the manufacturer's instructions. 
Results 
Phenotypic Analysis  of Mucosal Lymphoid  Tissue  in  TCR- 
a -/- Mice.  Histological examination  of colon  from  211 
TCR-c~ -/-  mice confirmed our previously reported find- 
ings (7) that IBD in TCR-~ -/-  mice develops by 20 wk of 
age. The frequency of IBD increased with age and was 60% 
by 20-25 wk, 83% by 25-30 wk, and 93% in mice over 30 
wk of age. Therefore, 20--26-wk-old TCR-~ -/- mice were 
used for the analysis of changes in the lymphoid tissue dur- 
ing the development of IBD. 
Since the inflammation noted in the colons of TCR-c~ -/- 
mice is apparently the result ofdysregulation of the mucosal 
immune  system,  we  were  interested in  performing a  de- 
tailed phenotypic and functional characterization of the gut- 
associated lymphoid tissue in these mice  (Table  1).  About 
50% of the lymphocytes isolated from the colon of TCR- 
a +/-  control  mice  were  TCR-cx/~+;  25%  of these  cells 
849  Mizoguchi et al. Table  1.  Phenotype  of Mesenteric Lymph Node Cells and Colonic Lymphocytes 
IBD  No. mice  Percent B220+CD3 -  Percent TCR-g +  tkatio TCtL-g/-[3 
Colon  8  31.8  +  4.4*  15.7  +  2.1  0.52  --+- 0.05 
TClt.-c~  +/-  -  (19  +  7)  :~  (9 +  3) 
MLN  18  39.0  -  3.4  1.2  -+ 0.2  0.04  -+ 0.01 
(346  --- 35)  (346  +  35) 
Colon  6  25.6  +  3.5  44.8  +  8.5  2.8  +-- 1.5 
TCII.-c~  -/-  -  (23 +  9)  (40 -  13) 
MLN  16  82.9  +  1.5  9.8 -+  1.9  2.4 +  0.4 
(1,738  _  382)  (205  -_ 45) 
Colon  13  40.9  -  5.5  50.7  +  6.6  5.7  -+ 0.9 
(108  +  48)  (135  +- 60) 
TCtL-cx  -/-  +  MLN  21  79.9  -+  1.4  15.7  +  2.3  6.9  +  0.9 
(4,123  +  477)  (810  -+ 93) 
Phenotype of colonic and MLN lymphocytes in diseased and nondiseased  TCtL-a -/- and TCP-.-ot  +/- mice was determined by flow cytometric 
analysis. All mice were maintained undesr pathogen-free conditions.  Mice are between 20 and 26 wk of age. 
*Data represent mean +  SEM. 
*The numbers in parentheses  indicate  the absolute numbers (￿  104) of positive cells in MLN. 
were CD4+CD8 -  and the remainder were CD4-CD8cx+/ 
[3 §  TCR-e~-/[3 +  lymphocytes  comprise  a  small  (11-13%) 
population  of  colonic  lymphocytes  in  TCR-cx -/-  mice 
(the  ratio  of TCIL-B/TCtL-[3  lymphocytes  is  about  5).  In 
diseased  mice  most  (>90%)  of these  TCtL-ot-/{3 +  cells 
were CD4 +  (in nondiseased TCR-cx -/-  mice, 70% TCR- 
cx-/[3 +  cells  express  CD4).  The  expanded  TCIL-~//B  +  T 
cell population  in  the  diseased  TCP,-cx -/-  mice was  pre- 
dominantly  (70%)  CD8oL+/I3-CD4 -  with a  smaller popu- 
lation  of CD4-CD8-  cells. We  did not  detect any  CD4 + 
TCtL-y/8 §  cells in the colons of these mice. 
The MLN  were markedly hyperplastic in mice with IBD 
and the number of cells obtained from the nodes increased 
dramatically with development oflBD  in TCtL-ot -/-  mice 
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Figure  1.  Total cell number of MLN from diseased and nondiseased 
TCtL-a  -/-  and  TCtL-c~  +/-  mice.  All  mice  were  maintained  under 
pathogen-free  conditions.  Mice are between 20 and 26 wk of age. IBD 
was diagnosed by histological analysis. 
(Fig. 1). The average number of cells from TCR-oL  +/- age- 
matched  control  and  TCtL-a -/-  mice  without  or  with 
IBD  was  1,083  +  90,  2,096  +  461,  and  5,160  +  597  ￿ 
104 cells, respectively. 
Like the colon, TCR-~//8 + T  cells were increased in the 
MLN  of TCtL-a -/-  mice both  with and without  IBD.  It 
is  interesting  to  note  that  there  was  a  greater  increase  of 
TCR-~//8 +  T  cells  in  TCIL-cx  -/-  mice  with  IBD  com- 
pared  to  TCtL-u -/-  mice without  IBD  (Fig.  2,  Table  1). 
Furthermore,  the  ratio  of  TCIL-~//8+/TCtl.-a-/[3  +  T 
cells was  markedly  increased  in  diseased  TCR-cx -/-  mice 
(6.9  +- 0.9)  compared to nondiseased mice (2.4  +  0.4)  (Ta- 
ble  1). The TCII.-~//8 + Tcell population was 63.5  +  5.2% 
CD4-CD8-  and 27.5  -+  3.2% CD4-CD8a  +.  Only 2.3  + 
0.2%  of the  MLN  cells  in  TCIL-a -/-  mice  were  TCtL- 
o~-/[3+; most (>90 %)  of these were CD4+CD8 -. 
The low numbers  of lymphocytes  present  in the  colons 
of diseased  mice  precluded  their  use  for  our  initial  func- 
tional studies  of T  cell subsets  in TCR-ot -/-  mice.  How- 
a +/-  r  "/- IBD  (-)  a -/-  IBD  (+) 
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0.6  " I~  ~ 0 7  2.0 
~-  i~, ........  ~----~, ...... 
TCR-8 
Figure 2.  Frequency ofTCP,-~//8  + T cells in MLN from diseased and 
nondiseased TCR-o~ -/- and  TCR-a +/- mice.  Mice are 20 wk of age. 
MLN cells were incubated  with FITC-anti-CD3e (145-2Cll), and PE- 
anti-TCR-~ (GL3) and then subjected to two-color flow cytometry anal- 
ysis. Percentages  of cells in quadrants  1,  2,  and  4 are  indicated  in the 
COITIers. 
850  Cytokine Imbalance and Autoantibody Production in TCtL-a Mutant Mice Figure 3.  Comparison of the frequency of spontaneous IL-2-, IL-4-, and IFN-'y-producing  MLN cells freshly extracted from diseased  TCR-ct  -/- 
and TCR-et  +/- mice. (A) Total MLN cells  were subjected to the cytokine-specific  IL-2, IL-4, and IFN-~/ELISPOT assay.  Values  are the mean ofSFC --- 
SEM from 8 separate experiments using 10 diseased  TCR-et  -/- (solid bar), 4 TCR ct  -/- mice without evidence of disease (dotted bar), and 8 TCR-et  +/- 
mice (open bar). (B) Representative photograph of  ELISPOT assay  showing IL-4- and IFN-'y--specific  spot production by freshly isolated MLN cells (2 ￿ 
10  s cells/well) from TCR oO/- mice and TCR et  -/- mice with IBD. 
ever,  as shown  in Table  1,  each of the phenotypic subsets 
of lymphocytes detected in  the  colon was  also present in 
the MLN,  the  first site of migration for cells sensitized in 
the intestinal epithehum,  and this tissue became  the  focus 
of our functional studies. 
Increase  of Spontaneous  IL-4-  and  IFN-'y--,  but  not  IL-2- 
secreting Cells in MLN  of Diseased TCR-a  -/-  Mice.  To exam- 
me  the  roles  of TCR-ot-/[3 +  and  TCR-~//8 +  T  cells in 
providing  help  for  Ig production  and  promoting  isotype 
switching in TCR-0~ -/- mice, we examined their ability to 
produce both Thl  (IL-2, IFN-~/) and Th2  (IL-4) cytokines 
using  an  ELISPOT  assay  as  described  in  Materials  and 
Methods.  As  shown  (Fig.  3,  A  and  B),  MLN  cells  from 
normal  TCR-oO/-  mice  secrete  small  amounts  of IL-4. 
The  number  of spontaneous  IL-4 SFC increased with the 
development oflBD from 8.6  --+ 3.7 per 106 cells in normal 
TCR-oO/-  mice to  137.0  -+  19.7  per  106  cells in TCR- 
ot -/-  mice with  IBD,  a  15-fold increase  (p  =  0.001).  An 
even more dramatic increase was observed for IFN-'y-pro- 
ducing SFC that were barely detectable (1.2  •  0.7)  in the 
MLN  of TCR-ct +/-  mice and increased to  261.6  --- 53.7 
in the MLN of diseased TCR-ct -/- mice. In contrast, spon- 
taneous  IL-2--secreting cells in  MLN  of TCR-ct -/-  mice 
were less compared to  TCR-tx +/-  mice.  To  confirm that 
our ELISPOT assay was capable of detecting IL-2-produc- 
ing cells, a  TCR-~//8 +  Tcell hybridoma  (1E6.11.D7;  22) 
stimulated with  plate-bound pan  8  antibody UC7-13D5, 
was  used  as  a  positive  control.  Almost  all  of these  cells 
could make spots (>80%). 
Pretreatment of MLN cells with 50  izg/ml of cyclohex- 
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imide, a protein synthesis inhibitor, reduced IL-4-produc- 
ing spots to 20% of their level in diseased TCR-ct  -/-  mice, 
indicating that the spots were the result of de novo protein 
synthesis during the 14-h assay incubation. 
These  observations  were  confirmed  by  examining  the 
expression of cytokine mRNA  in the MLN by RT-PCR. 
When  mRNA  extracted  from  unfractionated  MLN  cells 
from diseased TCR-ot -/-  mice was used, high density IL-4 
and IFN-~/bands were  noted.  However,  IL-4 and IFN-~/ 
mRNA  extracted from unfractionated MLN of TCR-oO/- 
mice was undetectable and slightly positive, respectively. In 
contrast with IL-4 and IFN-y mRNA,  the expression level 
Figure  4.  IL-2-, 1L-4-, and IFN-y- 
specific PCR analysis of freshly isolated 
total MLN cells  from diseased  TCR-ot -/- 
and  normal  TCR--~ +/-  mice.  Isolated 
mRNA was reverse transcribed and then 
amplified  by  IL-2,  IL-4,  IFN-~/ and 
13-actin 5'  and 3' primers using PCR. 
The length of amplified cDNA by IL-2, 
IL-4, IFN-~/and 13-actin  primers is 451, 
399, 405, and 245 bp, respectively. A 
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Figure  5.  (A)  Comparison of the frequency of 
spontaneous IL-4 and IFN-~/-producing cells in to- 
tal MLN  cells and CD3 + MLN cells (depleted  of 
adherent  and  B  cells) from  diseased  TCR-cx -/- 
mice.  (Open bars) Total  MLN  cells  (CD3 +,  10- 
20%); (solid  bars) CD3 + MLN cells (CD3 +, >93%). 
Values  are  the mean of SFC  •  SEM  from seven 
diseased  TCR.-oe -/-  mice  (five  separate  experi- 
ments).  (13) Enumeration  of  IL-4  SFC  in  anti- 
TCI<-[3  (H57-597),  anti-TCR-5  (UC7),  Con  A 
(5 ~g/ml), or hamster Ig (control)  in vitro-stimu- 
lated or nonstimulated CD3 + cells prepared from 
MLN of diseased TClk-ce -/- mice (20 wk of age). 
Values are the mean of IL-4 SFC  •  SEM in cells 
pooled from five  diseased TCP,-Ix -/-  mice (three 
separate experiments).  (C) Comparison of spontane- 
ous IFN-~ production in unfractionated MLN cells 
(total),  NK-l.l-depleted  fraction  (NK-1A-),  and 
NK-l.l-enriched  fraction  (NK-I.I+)  prepared 
from MLN of diseased TCR-0I -/- mice. Values are 
the mean of IFN-',/-SFC  •  SEM  in cells pooled 
from five diseased TCP,-~x -/- mice. Similar results 
were obtained from two additional experiments. 
of IL-2  mRNA  by  TCR-ot -/-  mice  was  reduced  com- 
pared to TCR-ot +/- mice (Fig.  4). 
Spontaneous  Secretion of IL-4  by  Both  TCR-ee-/~ §  and 
TCR-T/8 + T  Cells,  and  Predominant  Secretion of 1FN-T  by 
Non-T Cells in TCR-ee -/- Mice.  The  cytokine  imbalance 
revealed in the MLN  of diseased TCR-ot -/-  mice cannot, 
of  course,  be  explained  by  Thl/Th2  regulation  because 
these  mice  do  not  carry  TCR-~/~  T  cells.  Experiments 
were  performed  to  investigate the  cell type  responsible for 
secreting these cytokines in MLN  of TCk-ot  -/-  mice. Af'- 
Figure  6.  Two-color  immunohistochemical  analysis 
shows TCR.-'y/8-positive cells (blue), IL-4--positive  cells 
(red), and TCR-'y/8+,IL-4 + (purple; arrow)  in MLN from 
diseased TCla.-cx  -/- mice. 
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Figure  7.  Comparison of fre- 
quency  of total Ig,  IgM,  IgA, 
IgG1,  and  IgG2a  secreting 
B220  § CD3-  B  cells in  MLN 
from  diseased TCR--ot  -/-  and 
TCR-et +/- mice. Values are the 
mean oflg, lgM, IgA,  IgG1, and 
IgG2a SFC -4- SEM from 17 dis- 
eased TCR-et -/-  (solid bars), 8 
nondiseased TCR-c~  -/-  (dotted 
bar), and  14  TCR-a +/-  mice 
(open bars). 
ter  depletion  of B  cells  and  adherent  cells  (CD3 +  T  cells 
>93%),  the  ELISPOT assay showed an increase  of IL-4- 
secreting  cells  and  a  decrease  of IFN-'y-secreting cells  as 
compared to unfractionated MLN cells (Fig. 5 A). Among 
depleted cells, distinct CD3 or TCR-y/8  positive cells could 
not be found by immunohistochemical analysis ofcytospins 
from these preparations. This result suggests that IL-4 is se- 
creted by T  cells,  whereas  IFN-~/ appears  to be predomi- 
nandy secreted by non-T cells. 
To investigate whether either TCR-ot-/13 + or TCR-~// 
B  + T  cells  or  both  secrete  IL-4,  B-  and  adherent  cell- 
depleted MLN cells (CD3 + T  cells >93%) were stimulated 
for 3 h in vitro with plate-bound anti-TCR-[3 (H57-597) or 
anti-TCR-8 (UC7-13D5) before performing the ELISPOT 
assay.  Both anti-TCR-J3 and anti-TCR-8 were able to en- 
hance  the  production  of IL-4 by fivefold as  compared to 
nonstimulated cells  (p =  0.001; Fig. 5 B). This finding sug- 
gests that both  TCR-o~-/[3 +  and  TCR-',//8 +  T  cells  can 
secrete IL-4 upon TCR triggering. Although the T  cell pop- 
ulation in diseased MLN was composed of~80% TCR-',// 
8 + and ~<20% TCR-oe-/13 + T  cells,  the degree of increase 
was similar for anti-TCR-[3 and anti-TCR-~//8 stimulation. 
To obtain additional evidence for spontaneous secretion 
of IL-4 by TCR-0~-/~ +  and  TCR-~//B +  cells  in  situ  we 
perfomed two-color immunohistochemical analysis.  Stain- 
ing with  both  anti-TCR-',//8  (GL-3)  and  anti-IL-4  anti- 
bodies showed not only double positive  cells  (TCR-"//8 + 
IL-4+),  but  also  TCR-~/B-  IL-4  +  cells  in  T  cell  areas 
(containing  both  TCR-a-/[3 +  and  TCR-~//8 +  cells)  of 
MLN in diseased TCR-ci -/-  mice  (Fig.  6).  We were un- 
able  to directly demonstrate  double positive  TCR-o~-/[3 + 
IL-4  + cells using this technique because of the low expres- 
sion  level  of the  TCR-~  molecule  in  TCR<i -/-  mice. 
Nevertheless, this finding supports the result obtained using 
the  ELISPOT  assay  that  suggests  that  both  TCR-ot-/13 + 
and TCR-~/8 + T  cells spontaneously secrete IL-4. 
To examine which population among non-T cells produce 
IFN-% NK-I.1 + ceils (2-5% of MLN cells were NK-I.1 + 
in diseased TCR-~x -/-  mice)  were analyzed by ELISPOT 
assay after magnetic sorting. The NK-1.1-enriched fraction 
showed increased  IFN-',/  production  compared  to  unfrac- 
tionated  MLN  cells  (Fig.  5  C),  suggesting that  NK-I.1 + 
cells  are  a major source  of IFN-3, in  diseased  TCR-~x -/- 
mice.  IFN-~/  production  was  also  detectable  in  the  NK- 
1.1-depleted fraction, indicating that cells  other than NK- 
1.1 + cells  can also produce IFN-~/in diseased TCR-ot -/- 
mice. 
Isotype of lg Secreted  by MLN  B  Cells.  To  examine  the 
effect  of the  increased  secretion  of IL-4  and  IFN-'y  in 
MLN  of TCR-et -/-  mice  on  Ig synthesis,  the  frequency 
and the Ig isotypes were quantitated by ELISPOT assay us- 
ing  various  Ig isotype  antibodies  listed  in  Materials  and 
Methods. We found a marked increase  of B  cells secreting 
Ig in MLN of TCR-tx -/-  mice with IBD as compared to 
TCR-o~ -/-  mice without IBD and TCR-cx +/- mice (p  = 
0.001).  An ELISPOT assay using Ig isotype antibodies also 
showed that, in contrast to TCR-tz +/- mice,  IgA-, IgG1-, 
and IgG2a-secreting B  cells  (B220+CD3 -) were increased 
in MLN ofTCR-o~ -/- mice with IBD 3, 40, and 80 times, 
respectively  (Fig.  7).  However,  the  frequency  of IgM- 
secreting B  cells  revealed  no  obvious  difference  between 
these mice. These findings indicate that B cells in MLN of 
TCR-o~ -/-  mice with  IBD have been activated  resulting 
in Ig switching from IgM to IgA, IgGl,or IgG2a. The in- 
crease in IgG1- and IgG2a-secreting B  cells in the MLN of 
diseased mice parallels the increases in both IL-4 and IFN-2r 
suggesting that, in the absence ofTCR-oe/~ T  cells,  TCR- 
~//8 and TCR-ti-/[3 + T  cells  (IL-4), as well as non-T cells 
(IFN-"/)  can  support  switching  to  classically  Thl  (IgG1)- 
and Th2 (Ig2a)-dependent isotypes in the MLN of diseased 
TCR-ci -/- mice. 
We investigated whether the increase oflgG1- and IgG2a- 
secreting B cells in the MLN correlates with elevated serum 
Ig levels. ELISA showed significantly higher concentrations 
of IgG1 and IgG2a in the sera of diseased TCR-o~ -/- mice 
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Figure 8.  lgG1  and lgG2a concentrations in sera (1:100 dilution) from 
diseased TCR-~x  -/-, nondiseased TCR-c~  -/-, and TCR-tx §  mice as 
determined by ELISA. 
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Figure  9.  (A)  Comparison  of the  frequency  of 
B220 + CD3- cells producing an autoantibody against 
tropomyosin, a colonic cytoskeletal protein, in MLN 
from diseased TCR-~x  -/- and TCR.-~x  +/- mice. Val- 
ues are the mean of SFC  -+ SEM from  15 diseased 
TCR.-c~  -/- (solid bars), 6 nondiseased TCl<-~x-/-(dotted 
bar), and 11 TCI<-~  +/- mice (open bars). (t5') Isotype of 
autoantibody against tropomyosni secreted by B cells in 
MLN from nondiseased (open bars) and diseased (solid 
bars) TCl<-ot -/- mice (20--24 wk of age). 
compared  with  TCR-ix +/-  or  TCR-ix -/-  mice  without 
disease (Fig. 8). 
Switching of Autoantibodies against  Tropomyosin.  If the  IBD 
observed in TCR.-ix -/-  mice is the  result  of uncontrolled 
reactivity  to  self-antigens  (or lumenal  antigens  cross-reac- 
tive with self-antigens),  one might expect to find autoanti- 
bodies to cellular constitutents  in the sera of diseased mice. 
Antibodies to the cytoskeletal protein tropomyosin have been 
reported in patients with UC  (17). We therefore examined 
autoreactivity to tropomyosin in both normal (TCR-ix +/-) 
and  TCP,.-ix -/-  mice with  and without  IBD.  An  average 
of 38.1  +  10.2 anti-tropomyosin--secreting cells/106 ]3 cells 
(B220+CD3 -)  was detectable  in the  MLN  of TCR-ix +/- 
mice. In MLN of diseased TCR.-ix -/-  mice, anti-tropomy- 
osin-secreting B cells increased to 478.6  +  104.0,  a 15-fold 
increase over the number of cells in TCR.-ix +/- mice (Fig. 
9, p  =  0.001).  Moreover,  this increase correlated with  the 
development of disease since autoantibody production was 
only modestly increased in TClk-ix -/- mice without histo- 
logical evidence of IBD. The predominant isotype compo- 
sition  of the  autoantibody  was  IgM  in  TCR--IX  -/-  mice 
without  IBD;  however,  the  isotype  of the  autoantibody 
was changed to IgG, especially IgG2a, in TClk-ix -/-  with 
IBD, indicating  that switching  of autoantibodies  had been 
induced  (Fig.  9).  Therefore,  this  finding  also  supports  the 
notion  that  the  cytokine  profile  of MLN  in  TCR-IX -/- 
mice  also  induces  the  switching  of autoantibodies  from 
IgM to IgG (predominantly IgG2a). 
Discussion 
Most antibody responses to protein antigens are T  cell de- 
pendent because they require help, in the form of cytokines, 
from CD4 +  T  cells.  Some antigens have been  classified as 
"T-independent"  in  that they  ehcit antibody  responses  in 
athymic mice. TClk-ix -/-  mice respond weakly to classical 
"T-dependent" antigens, such as ovalbumin but respond well 
to prototypical T  independent antigens, such as phosphoryl- 
choline and TNP-LPS (8). It is clear that, whereas responses 
to  T-independent  antigens  do  not  require  TCI~.-<x/J3  T 
cells, they do require T  cell-derived cytokines (23). However, 
many non-T cells can also secrete cytokines that may play a 
role in B  cell maturation and class switching (24). We have 
found  that,  although  IL-2 production  is greatly decreased 
in the absence ofTCR-ix/J3 T  cells in the MLN of diseased 
TCk-ix -/-  mice, spontaneous  secretion  of both  IL-4 and 
IFN-~t is markedly increased.  Both the proportion and ab- 
solute  number of ~//8  T  cells is increased  in  the  MLN  of 
TCR  ix -/_  mice  (Table  1).  Whereas  they  are  apparently 
unable  to  substitute  for TCP.-ix/[3  T  cells in  a  T-depen- 
dent antibody response, ~//B T  cells are likely to play a role 
in the T-independent  responses noted in TCR-ix -/-  mice. 
The  general rules for antigen  recognition  by TCR-y/8  T 
cells  and  their  role  in  immune  responsiveness  in  normal 
mice are not clear.  However,  a recent report (25)  suggests 
that infection  of mice with  the  mucosal  pathogen  Nippo- 
strongylus  brasiliensis,  known  to be a potent inducer of Th2 
cells,  is  characterized  by  the  early  appearance  of IL-4- 
secreting  TCP.-y/~  T  cells.  By contrast,  IFN-y-secreting 
TCP.-',//B  T  cells  predominate  in  response  to  the  Thl- 
stimulating  pathogen  Listeria  monocytogenes  (25).  These  re- 
sults suggest that TCP.-y/8  T  cells can function in the  es- 
tablishment of an immune response and that their secretion 
of cytokines may influence the subsequent  development of 
Thl  and/or  Th2  subsets  of TCP.-ix/~  T  cells later in in- 
fection. 
TCR-ix-/~ +  T  cells seem to play an important  role in 
the  development  of IBD  since  TCP.-~3 -/-  mice  (which 
lack any residual population ofTCR-ix-/13 + or TCP.-ix+/ 
[3- cells) have a milder form of this disease (7). The surface 
expression  of a TCR-[3  chain in the  absense of a TCP-.-ix 
chain  (TCK-ix-/J3 +)  has been  reported  in  the  thymus  of 
recombination activating gene (RAG)  1 and 2 mutant mice 
with TClq.-J3 transgene  (26-28).  However, the function of 
TClq.-ix-/13 +  T  cells in  these  mice  remains  unclear  since 
these cells are unstable and undetectable in peripheral organs. 
An  unusual  population  of TCP.-ix-/{3 +  cells is present  in 
the  thymus and peripheral  organs of TCtk-ix -/-  mice  (8). 
The TCR-J3  chain  on the  TCP.-ix-/13 +  subset of cells in 
the thymus is found in association with a previously unde- 
scribed 33-kD  protein that may play a role in early T  cell 
development  (29).  Other work has shown  that TClq.-cx-/ 
[3 +  cells derived from bronchoalveolar  lavage of influenza 
virus-infected TCR-ix -/- mice can demonstrate functional 
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ylococcus enterotoxin B) superantigens in the absence of a 
detectable response to viral antigens  (30).  This dichotomy 
may reflect differences in  the  way that  superantigens  and 
conventional antigens stimulate T  cells. However, we show 
here  that  TCR-~-/[3 +  cells  are  also  responsive  (as  mea- 
sured by IL-4 secretion) to TCR  cross-linking with plate- 
bound  anti-TCR-[~  antibody  (Fig.  5  B),  a  form of TCR 
stimulation often used as a model for conventional antigen- 
MHC interactions. The ternary TCR-ot/[3-antigen-MHC 
complex is involved in determining Th development (31, 
32). It is possible that the lack of a TCR-Ix chain on T  cells 
results in the skewed development of Th subsets (Th2 but 
not  Thl)  in  TCR-~ -/-  mice.  Alternatively,  by analogy 
with the  Nippostrongylus model noted above, the early in- 
duction of IL-4-secreting TCR-~//8 T  cells may drive the 
smaller population  of CD4 +  TCR-Ix-/[~  +  cells  toward  a 
Th2  (IL-4)-secreting phenotype.  In the absence of TCR- 
ot/[~  T  cells,  autoantigen  recognition  may  proceed  un- 
checked  and  the  resultant  continued  IL-4  secretion  may 
function both in B  cell activation and switching to drive a 
Th2-dependent  autoantibody response  (7).  IL-4-activated 
B  cells  can  induce  IFN-~/  production  by  NK  cells  (33) 
which  are unimpaired in TCR-a -/-  mice  (8,  and  Fig.  5 
C). IFN-~/released by activated NK cells can induce IgG2a 
class switching  (34).  In TCR-~x -/-  mice,  both NK-I.1 + 
and NK-I.1- cells can produce IFN-% This induced  (and 
unregulated) IFN-~/production might then drive switching 
of a Thl-dependent  autoantibody response.  In support of 
this scenario, we have noted that IL-4 secretion by MLN 
cells  from TCR-0t  -/-  mice tends  to  increase  earlier than 
IFN-~ (our unpublished observations). 
Indeed,  we present  evidence for autoantibody produc- 
tion of both Thl  (tgG2a)- and Th2  (IgG1)-dependent Ig 
isotypes in diseased TCR-ot  -/-  mice (Fig.  9).  In a recent 
study  (9),  autoantibodies  of IgG  subclass  were  demon- 
strated in ~50%  of sera from another line  of TCR-ot  -/- 
mice after 5 wk of age. The antibodies included anti-DNA, 
antinuclear  antibody,  and antibodies  reactive with human 
cell proteins and murine small nuclear ribonucleoproteins. 
We  chose  to  focus  on  the  humoral  immune  response to 
tropomyosin because of the prevalence of antitropomyosin 
autoantibodies  in  a large percentage of patients with UC 
(17,  35).  Cross-reactivity for tropomyosin with a bacterial 
protein  has  been  demonstrated  for  group  A  streptococci 
(36),  suggesting the interesting possibility that an autoim- 
mune  response to  colonic  epithelial  tropomyosin is  initi- 
ated by a cross-reactive antibody response elicited by anti- 
gens on the surface of  bacteria (e.g., bacterial polysaccharides 
or LPS) in the intestinal lumen. The development of IBD 
in mice in which the mucosal immune response is dysregu- 
lated by a mutation in the IL-2 gene is abrogated by rearing 
the mice in a germ-free environment (37).  If this observa- 
tion is also true for TCR-0~ -/- mice raised in a germ-free 
environment, it would provide further support for the idea 
that  cross-reactivity to  constituents  of the  bacterial  flora 
play a role in driving this disease. 
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